Drug Profile
Glycopyrrolate bromide - Proveca
Alternative Names: SialanarLatest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator Proveca
- Class Antiasthmatics; Antispasmodics; Antiulcers; Pyrrolidines; Quaternary ammonium compounds; Skin disorder therapies; Small molecules
- Mechanism of Action Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Sialorrhoea
Most Recent Events
- 30 Jan 2019 Chemical structure information added
- 07 Sep 2018 Launched for Sialorrhoea (In adolescents, In children, In infants) in Sweden, Ireland, Germany, Norway, Denmark (PO)
- 09 Jun 2017 Glycopyrrolate (Sialanar®, 320 µg/ml) is available on a Named Patient Access Programme for the treatment of Sialorrhoea in World excluding Europe and USA